FLT1 and neoplasm: FLT1 has limited kinase activity but exhibits proangiogenic tyrosine kinase activity alongside its suppressive function facilitated by the physiological splice variant.[80] These FLT1+ ECs influence the TME through tumor microvessel formation and consequently cause resistance to ICB.[81]